Company registration number 11038741 (England and Wales)
MEDILINK MIDLANDS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
MEDILINK MIDLANDS LIMITED
COMPANY INFORMATION
Directors
Mr M Levermore
Mr K Widdowson
Prof Y Barnett
Prof M Bennett
Dr D Mead
Mr C De Rohan
Dr A Ghadar
M Davidson
(Appointed 23 April 2024)
Dr E Trunchanowicz
(Appointed 21 October 2024)
Dr M Eccleston
(Appointed 21 October 2024)
Secretary
Mrs A Dawson
Company number
11038741
Registered office
Antenna Media Centre
Beck Street
Creative Quarter
Nottingham
NG1 1EQ
Auditor
Rogers Spencer
Newstead House
Pelham Road
Nottingham
NG5 1AP
MEDILINK MIDLANDS LIMITED
CONTENTS
Page
Directors' report
1 - 2
Directors' responsibilities statement
3
Independent auditor's report
4 - 7
Profit and loss account
8
Group balance sheet
9
Company balance sheet
10
Notes to the financial statements
11 - 16
MEDILINK MIDLANDS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -
The directors present their annual report and financial statements for the year ended 31 March 2025.
Principal activities
The principal activity of the group continued to be that of the provision of a support organisation for the healthcare sector with its core objective being to help the healthcare sector SME's in the East and West Midlands to establish, grow and develop.
The company is a not for profit organisation, limited by guarantee and any income surpluses made are used to further the company's core objective.
Results and dividends
This is the first year that all contracts have been taken on fully by Medilink Midlands, since the consolidation of East Midlands Limited and Medilink West Midlands Limited. All membership and events are now also being run by Medilink Midlands Limited. The intention is that in the coming years, Medilink Midlands Limited will continue to carry out the same business activities as Medilink East Midlands Limited and Medilink West Midlands Limited did previously, those being to deliver public funded business support programmes exclusively to the HealthTech/MedTech sector on a not-for-profit basis. Our activities date back over 20 years. Given the collective reserves of the organisations we will be able to meet our foreseeable ongoing obligations.
Going forward the risk and audit committee concluded that an audit or assurance will be performed on Medilink Midlands Limited for the current financial year and subsequent years thereafter, to ensure that Medilink Midlands Limited are continued to be viewed positively by public sector and commercial organisations.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Dr D Clark
(Resigned 9 May 2025)
Mr M Levermore
Mr K Widdowson
Prof Y Barnett
Prof M Bennett
Dr D Mead
Mr C De Rohan
Dr A Ghadar
M Davidson
(Appointed 23 April 2024)
Dr E Trunchanowicz
(Appointed 21 October 2024)
Dr M Eccleston
(Appointed 21 October 2024)
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
Small companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
MEDILINK MIDLANDS LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
On behalf of the board
Mr M Levermore
Director
16 July 2025
MEDILINK MIDLANDS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
MEDILINK MIDLANDS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF MEDILINK MIDLANDS LIMITED
- 4 -
Opinion
We have audited the financial statements of Medilink Midlands Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 March 2025 which comprise the group profit and loss account, the group balance sheet, the company balance sheet and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 March 2025 and of the group's loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The directors' report has been prepared in accordance with applicable legal requirements.
MEDILINK MIDLANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF MEDILINK MIDLANDS LIMITED
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the directors' report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit; or
the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and from the requirement to prepare a strategic report.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
MEDILINK MIDLANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF MEDILINK MIDLANDS LIMITED
- 6 -
The extent to which the audit was considered capable of detecting irregularities including fraud.
Our approach to identifying and assessing the risk of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
The engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
We identified the laws and regulations applicable to the company through discussions with directors and other management, and from our commercial knowledge and experience of the healthcare sector;
We focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the company, including the Companies Act 2006, taxation legislation and data protection, anti-bribery, employment, environmental and health and safety legislation;
We assessed the extent of compliance with the laws and regulations identified above through making enquiries of management.
Identified laws and regulations were communicated within the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.
We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
Making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud;
Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations; and
Understanding the design of the company’s remuneration policies.
To address the risk of fraud through management bias and override of controls, we:
Performed analytical procedures to identify any unusual or unexpected relationships;
Tested journal entries to identify unusual transactions;
Investigated the rationale behind significant or unusual transactions.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
Agreeing financial statement disclosures to underlying supporting documentation;
Reading the minutes of meetings of those charged with governance;
Enquiring of management as to actual and potential litigation and claims; and
Reviewing correspondence with HMRC, relevant regulators and the company’s legal advisors.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
MEDILINK MIDLANDS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF MEDILINK MIDLANDS LIMITED
- 7 -
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Alistair Allcock (Senior Statutory Auditor)
For and on behalf of Rogers Spencer
17 July 2025
Chartered Accountants
Statutory Auditor
Newstead House
Pelham Road
Nottingham
NG5 1AP
MEDILINK MIDLANDS LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Turnover
1,259,016
1,839,221
Administrative expenses
(1,402,295)
(1,816,673)
Operating (loss)/profit
(143,279)
22,548
Interest receivable and similar income
4
13,227
58
(Loss)/profit before taxation
(130,052)
22,606
Tax on (loss)/profit
(2,526)
(11)
(Loss)/profit for the financial year
(132,578)
22,595
(Loss)/profit for the financial year is all attributable to the owners of the parent company.
MEDILINK MIDLANDS LIMITED
GROUP BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
5
189
Tangible assets
6
17,467
10,224
17,467
10,413
Current assets
Debtors
7
315,049
320,009
Investments
8
400,927
400,000
Cash at bank and in hand
267,838
663,932
983,814
1,383,941
Creditors: amounts falling due within one year
9
(119,579)
(380,074)
Net current assets
864,235
1,003,867
Net assets
881,702
1,014,280
Capital and reserves
Called up share capital
Other reserves
739,227
739,227
Profit and loss reserves
142,475
275,053
Total equity
881,702
1,014,280
These financial statements have been prepared in accordance with the provisions applicable to groups and companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 16 July 2025 and are signed on its behalf by:
16 July 2025
Mr M Levermore
Director
Company registration number 11038741 (England and Wales)
MEDILINK MIDLANDS LIMITED
COMPANY BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 10 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
6
17,467
7,244
Current assets
Debtors
7
315,049
304,200
Investments
8
400,927
400,000
Cash at bank and in hand
267,838
608,133
983,814
1,312,333
Creditors: amounts falling due within one year
9
(119,579)
(1,271,590)
Net current assets
864,235
40,743
Net assets
881,702
47,987
Capital and reserves
Called up share capital
Profit and loss reserves
881,702
47,987
Total equity
881,702
47,987
As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £833,715 (2024 - £148,502 profit).
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 16 July 2025 and are signed on its behalf by:
16 July 2025
Mr M Levermore
Director
Company registration number 11038741 (England and Wales)
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
1
Accounting policies
Company information
Medilink Midlands Limited is a private company limited by guarantee incorporated in England and Wales.
The registered office is Antenna Media Centre, Beck Street, Nottingham, England, NG1 1EQ.
On 1st April 2021 Medilink Midlands Limited became the relevant parent legal enity of Medilink East Midlands Limited and Medilink West Midlands Limited.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Medilink Midlands Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 March 2025. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 12 -
1.4
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
When cash inflows are deferred and represent a financing arrangement, the fair value of the consideration is the present value of the future receipts. The difference between the fair value of the consideration and the nominal amount received is recognised as interest income.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.5
Intangible fixed assets other than goodwill
Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.
Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Software
3 year straight line
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Fixtures and fittings
3 year straight line
Computers
3 year straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
1.7
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.10
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.11
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
1.12
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 14 -
3
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2025
2024
2025
2024
Number
Number
Number
Number
Total
18
21
18
9
4
Interest receivable and similar income
2025
2024
£
£
Other interest receivable and similar income
13,227
58
5
Intangible fixed assets
Group
Software
£
Cost
At 1 April 2024 and 31 March 2025
6,466
Amortisation and impairment
At 1 April 2024
6,277
Amortisation charged for the year
189
At 31 March 2025
6,466
Carrying amount
At 31 March 2025
At 31 March 2024
189
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 15 -
6
Tangible fixed assets
Group
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 April 2024
14,925
17,190
32,115
Additions
14,902
14,902
Disposals
(402)
(402)
At 31 March 2025
14,925
31,690
46,615
Depreciation and impairment
At 1 April 2024
12,779
9,112
21,891
Depreciation charged in the year
2,146
5,255
7,401
Eliminated in respect of disposals
(144)
(144)
At 31 March 2025
14,925
14,223
29,148
Carrying amount
At 31 March 2025
17,467
17,467
At 31 March 2024
2,146
8,078
10,224
Company
Fixtures and fittings
Computers
Total
£
£
£
Cost
At 1 April 2024
10,908
10,908
Additions
14,902
14,902
Disposals
(58,136)
(1,152)
(59,288)
Transfers
73,061
7,032
80,093
At 31 March 2025
14,925
31,690
46,615
Depreciation and impairment
At 1 April 2024
3,664
3,664
Depreciation charged in the year
2,146
5,255
7,401
Eliminated in respect of disposals
(58,136)
(895)
(59,031)
Transfers
70,915
6,199
77,114
At 31 March 2025
14,925
14,223
29,148
Carrying amount
At 31 March 2025
17,467
17,467
At 31 March 2024
7,244
7,244
MEDILINK MIDLANDS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 16 -
7
Debtors
Group
Company
2025
2024
2025
2024
Amounts falling due within one year:
£
£
£
£
Trade debtors
49,805
92,487
49,805
77,488
Other debtors
265,244
227,522
265,244
226,712
315,049
320,009
315,049
304,200
8
Current asset investments
Group
Company
2025
2024
2025
2024
£
£
£
£
Investments
400,927
400,000
400,927
400,000
9
Creditors: amounts falling due within one year
Group
Company
2025
2024
2025
2024
£
£
£
£
Trade creditors
4,338
49,108
4,338
49,108
Corporation tax payable
2,513
3
2,513
Other taxation and social security
19,640
32,856
19,640
9,526
Other creditors
93,088
298,107
93,088
1,212,956
119,579
380,074
119,579
1,271,590
2025-03-312024-04-01falsefalseCCH SoftwareCCH Accounts Production 2025.100Dr D ClarkMr M LevermoreMr K WiddowsonProf Y BarnettProf M BennettDr D MeadMr C De RohanDr A GhadarM DavidsonDr E TrunchanowiczDr M EcclestonMrs A Dawsonfalse11038741bus:Consolidated2024-04-012025-03-31110387412024-04-012025-03-3111038741bus:Director22024-04-012025-03-3111038741bus:Director32024-04-012025-03-3111038741bus:Director42024-04-012025-03-3111038741bus:Director52024-04-012025-03-3111038741bus:Director62024-04-012025-03-3111038741bus:Director72024-04-012025-03-3111038741bus:Director82024-04-012025-03-3111038741bus:Director92024-04-012025-03-3111038741bus:Director102024-04-012025-03-3111038741bus:Director112024-04-012025-03-3111038741bus:CompanySecretary12024-04-012025-03-3111038741bus:Director12024-04-012025-03-3111038741bus:RegisteredOffice2024-04-012025-03-3111038741bus:Consolidated2025-03-31110387412025-03-3111038741bus:Consolidated2023-04-012024-03-3111038741bus:Consolidated2024-03-3111038741core:ComputerSoftwarebus:Consolidated2025-03-3111038741core:ComputerSoftwarebus:Consolidated2024-03-31110387412024-03-3111038741core:FurnitureFittingsbus:Consolidated2025-03-3111038741core:ComputerEquipmentbus:Consolidated2025-03-3111038741core:FurnitureFittingsbus:Consolidated2024-03-3111038741core:ComputerEquipmentbus:Consolidated2024-03-3111038741core:FurnitureFittings2025-03-3111038741core:ComputerEquipment2025-03-3111038741core:FurnitureFittings2024-03-3111038741core:ComputerEquipment2024-03-3111038741core:ShareCapitalbus:Consolidated2025-03-3111038741core:ShareCapitalbus:Consolidated2024-03-3111038741core:OtherMiscellaneousReservebus:Consolidated2025-03-3111038741core:OtherMiscellaneousReservebus:Consolidated2024-03-3111038741core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-03-3111038741core:ShareCapital2025-03-3111038741core:ShareCapital2024-03-3111038741core:RetainedEarningsAccumulatedLosses2025-03-3111038741core:RetainedEarningsAccumulatedLosses2024-03-3111038741core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3111038741core:ComputerSoftware2024-04-012025-03-3111038741core:FurnitureFittings2024-04-012025-03-3111038741core:ComputerEquipment2024-04-012025-03-31110387412023-04-012024-03-3111038741core:ComputerSoftwarebus:Consolidated2024-03-3111038741core:ComputerSoftwarebus:Consolidated2024-04-012025-03-3111038741core:FurnitureFittingsbus:Consolidated2024-03-3111038741core:ComputerEquipmentbus:Consolidated2024-03-3111038741bus:Consolidated2024-03-3111038741core:FurnitureFittings2024-03-3111038741core:ComputerEquipment2024-03-31110387412024-03-3111038741core:FurnitureFittingsbus:Consolidated2024-04-012025-03-3111038741core:ComputerEquipmentbus:Consolidated2024-04-012025-03-3111038741core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-03-3111038741core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-03-3111038741core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3111038741core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111038741core:CurrentFinancialInstrumentsbus:Consolidated2025-03-3111038741core:CurrentFinancialInstrumentsbus:Consolidated2024-03-3111038741core:CurrentFinancialInstruments2025-03-3111038741core:CurrentFinancialInstruments2024-03-3111038741bus:PrivateLimitedCompanyLtd2024-04-012025-03-3111038741bus:FRS1022024-04-012025-03-3111038741bus:Audited2024-04-012025-03-3111038741bus:ConsolidatedGroupCompanyAccounts2024-04-012025-03-3111038741bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP